MedPath

Celltrion Healthcare Australia Pty Ltd.

🇦🇺Australia
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

35

TGA:35

Drug Approvals

AVTOZMA tocilizumab (rch) 162 mg/0.9 mL solution for injection pre-filled syringe (444942)

Product Name
AVTOZMA tocilizumab (rch) 162 mg/0.9 mL solution for injection pre-filled syringe
Approval Date
May 30, 2025
TGA

AVTOZMA tocilizumab (rch) 80 mg/4 mL injection concentrated vial (444940)

Product Name
AVTOZMA tocilizumab (rch) 80 mg/4 mL injection concentrated vial
Approval Date
May 30, 2025
TGA

AVTOZMA tocilizumab (rch) 400 mg/20 mL injection concentrated vial (444943)

Product Name
AVTOZMA tocilizumab (rch) 400 mg/20 mL injection concentrated vial
Approval Date
May 30, 2025
TGA

AVTOZMA tocilizumab (rch) 200 mg/10 mL injection concentrated vial (444939)

Product Name
AVTOZMA tocilizumab (rch) 200 mg/10 mL injection concentrated vial
Approval Date
May 30, 2025
TGA

AVTOZMA tocilizumab (rch) 162 mg/0.9 mL solution for injection pre-filled pen, AVTPen Autoinjector (444941)

Product Name
AVTOZMA tocilizumab (rch) 162 mg/0.9 mL solution for injection pre-filled pen, AVTPen Autoinjector
Approval Date
May 30, 2025
TGA

STOBOCLO denosumab (rch) 60 mg/mL solution for injection pre-filled syringe (442991)

Product Name
STOBOCLO denosumab (rch) 60 mg/mL solution for injection pre-filled syringe
Approval Date
Apr 4, 2025
TGA

OSENVELT denosumab (rch) 70 mg/mL solution for injection vial (442990)

Product Name
OSENVELT denosumab (rch) 70 mg/mL solution for injection vial
Approval Date
Apr 4, 2025
TGA

EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection vial with needle (431932)

Product Name
EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection vial with needle
Approval Date
Mar 31, 2025
TGA

EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringe (431931)

Product Name
EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringe
Approval Date
Mar 31, 2025
TGA

OMLYCLO omalizumab (rch) 75 mg/0.5 mL solution for injection in a pre-filled syringe with needle guard (427223)

Product Name
OMLYCLO omalizumab (rch) 75 mg/0.5 mL solution for injection in a pre-filled syringe with needle guard
Approval Date
Nov 26, 2024
TGA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.